Chordate Medical Holding AB (OSTO:CMH) Cash per Share: kr1.57 (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:CMH Chordate Medical Holding AB OSTO:CMH
46 GF Score
Price kr0.16
View Full Analysis

What is Chordate Medical Holding AB Cash per Share?

Chordate Medical Holding AB OSTO:CMH -60.40% 46 Cash per Share is kr1.57 as of Jun. 2025. GuruFocus rates OSTO:CMH with a GF Score™ of 46/100.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Chordate Medical Holding AB's Cash per Share for the quarter that ended in Jun. 2025 was kr1.57.

Chordate Medical Holding AB  (OSTO:CMH) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Chordate Medical Holding AB Cash per Share Related Terms

Chordate Medical Holding AB Cash per Share Historical Data

* Premium members only.

The historical data trend for Chordate Medical Holding AB's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordate Medical Holding AB Cash per Share Chart

Chordate Medical Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.05 43.80 6.29 9.82 1.62

Chordate Medical Holding AB Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.38 3.23 1.62 4.76 1.57
OSTO:CMH
46GF Score
Chordate Medical Holding AB OSTO:CMH
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chordate Medical Holding AB Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Chordate Medical Holding AB's Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=2.529506/1.56
=1.62

Chordate Medical Holding AB's Cash per Share for the quarter that ended in Jun. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=4.24374/2.70
=1.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of kr1.57 mean?
Chordate Medical Holding AB (OSTO:CMH) has a Cash per Share of kr1.57 as of Jun. 2025. Cash per share is the per-share value of a company's available cash. View historical data for Chordate Medical Holding AB and its competitors.
Is Chordate Medical Holding AB's Cash per Share too high?
Chordate Medical Holding AB's current Cash per Share is kr1.57. Overall, Chordate Medical Holding AB has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Chordate Medical Holding AB's Cash per Share compare to ABT and SYK?
Chordate Medical Holding AB's Cash per Share of kr1.57 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Devices & Instruments company?
A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Chordate Medical Holding AB and its competitors. Chordate Medical Holding AB's current Cash per Share is kr1.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chordate Medical Holding AB stock overvalued right now?
Chordate Medical Holding AB (OSTO:CMH) has a current Cash per Share of kr1.57. The current Cash per Share is kr1.57. Chordate Medical Holding AB's overall GF Score™ is 46/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Chordate Medical Holding AB (OSTO:CMH), the current Cash per Share is kr1.57 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chordate Medical Holding AB Business Description

Address Farogatan 33, 164 51 Kista, Kista, SWE, 164 40
Chordate Medical Holding AB is a Swedish medical technology company that develops and commercializes nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. Its product range is built around the CE-marked Chordate System, including the S100 and S120 units for rhinitis and the S220 unit for migraine, which are registered for preventive treatment of chronic migraine and chronic rhinitis. The company sells its treatment systems, along with associated treatments, through distributors to clinics and hospitals. Its primary markets include selected European countries, Israel, and Saudi Arabia. Revenue is generated through the sale of treatment systems and related treatments via its distributor network. The company is based in Sweden and focuses on providing non-invasive treatment options for patients suffering from chronic nasal congestion and chronic migraine.
46GF Score

Get the complete analysis for OSTO:CMH

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.16
Price